United Therapeutics (UTHR) EPS (Diluted) (QoQ) (2009 - 2026)
Powered by 
Analysis
United Therapeutics (UTHR) EPS (Diluted) (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.92 Bn | 626.16 Bn | 17.26 Bn |
| 2 | AbbVie | 441.93 Bn | 435.36 Bn | 12.70 Bn |
| 3 | Merck | 365.88 Bn | 358.74 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn |
| 5 | Pfizer | 159.09 Bn | 147.39 Bn | 10.94 Bn |
| 6 | Sanofi | 52.44 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 8 | Incyte | 25.31 Bn | 20.78 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.45 Bn | 18.78 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.53 Bn | 15.15 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.84% |
| Mar 31, 2026 | -23.42% |
| Dec 31, 2025 | 6.21% |
| Sep 30, 2025 | 11.75% |
| Jun 30, 2025 | -3.35% |
| Mar 31, 2025 | 6.72% |
| Dec 31, 2024 | -2.72% |
| Sep 30, 2024 | 9.08% |
| Jun 30, 2024 | -5.09% |
| Mar 31, 2024 | 41.23% |
| Dec 31, 2023 | -18.87% |
| Sep 30, 2023 | 2.83% |
| Jun 30, 2023 | 7.81% |
| Mar 31, 2023 | 78.32% |
| Dec 31, 2022 | -44.57% |
| Sep 30, 2022 | 103.75% |
| Jun 30, 2022 | -52.05% |
| Mar 31, 2022 | 112.02% |
| Dec 31, 2021 | -30.60% |
| Sep 30, 2021 | -6.33% |